scPharmaceuticals Inc (SCPH)
4.66
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
4.65
-0.01
(-0.21%)
After-Hours: 20:00
scPharmaceuticals Total Assets (Quarterly): 94.48M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 94.48M |
| September 30, 2023 | 106.10M |
| June 30, 2023 | 114.17M |
| March 31, 2023 | 127.37M |
| December 31, 2022 | 124.20M |
| September 30, 2022 | 48.40M |
| June 30, 2022 | 59.16M |
| March 31, 2022 | 68.89M |
| December 31, 2021 | 79.04M |
| September 30, 2021 | 87.53M |
| June 30, 2021 | 93.62M |
| March 31, 2021 | 100.29M |
| December 31, 2020 | 109.05M |
| September 30, 2020 | 116.96M |
| Date | Value |
|---|---|
| June 30, 2020 | 123.92M |
| March 31, 2020 | 80.49M |
| December 31, 2019 | 77.28M |
| September 30, 2019 | 86.67M |
| June 30, 2019 | 83.46M |
| March 31, 2019 | 87.59M |
| December 31, 2018 | 93.76M |
| September 30, 2018 | 98.82M |
| June 30, 2018 | 105.01M |
| March 31, 2018 | 113.65M |
| December 31, 2017 | 122.05M |
| September 30, 2017 | 33.93M |
| December 31, 2016 | 39.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
48.40M
Minimum
Sep 2022
127.37M
Maximum
Mar 2023
93.74M
Average
93.62M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics Inc | 270.63M |
| Spero Therapeutics Inc | 182.39M |
| electroCore Inc | 16.10M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 57.26M |
| Shareholders Equity (Quarterly) | 37.22M |
| Debt to Equity Ratio | 1.043 |
| Current Ratio | 7.076 |
| Net Debt Paydown Yield | -0.12% |